1. Signaling Pathways
  2. Others
  3. Others
  4. Others Inhibitor

Others Inhibitor

Others Inhibitors (61):

Cat. No. Product Name Effect Purity
  • HY-22166
    Glycolic acid oxidase inhibitor 1
    Inhibitor 99.35%
    Glycolic acid oxidase inhibitor 1 is a glycolate oxidase inhibitor, extracted from patent EP0021228A1, in Table IV.
  • HY-129902
    L-Acosamine nucleoside
    Inhibitor
    L-Acosamine nucleoside is a furanose-configured glycoside with potential antiviral activity.
  • HY-165315
    Lysyl-serine
    Inhibitor
    Lysyl-serine (TCMP-80) is a T cell modulatory peptide with immunomodulatory properties.
  • HY-135593
    LY88074 analog 1
    Inhibitor
    LY88074 analog 1 is a benzothiophene compound with nitrogen-containing non-basic side chains, Compound 26, extracted from patent EP0747380A1. LY88074 analog 1 is an agent for alleviating the symptoms of post-menopausal symptoms, such as osteoporosis, cardiovascular related pathological conditions, and estrogen-dependent cancer. LY88074 analog 1 can be used alone or in combination with estrogen or progestin.
  • HY-129450
    Ethyl-L-NIO hydrochloride
    Inhibitor
    Ethyl-L-NIO hydrochloride is a potent and competitive human dimethylarginine dimethylaminohydrolase 1 (hDDAH-1) inhibitor with an IC50 of 70 μM and a Ki of 32 μM.
  • HY-159820
    Veonetinib
    Inhibitor
    Veonetinib (example 3) is a potent inhibitor of tyrosine kinase, with the IC50 of 0.1 μM and 0.4 μM in A549 cells and LOVO cells, respectively.
  • HY-159837
    Nispomeben
    Inhibitor
    Nispomeben is a potent non-opioid pain relief drug.
  • HY-186161
    Antiproliferative agent-77
    Inhibitor
    Antiproliferative agent-77 is an anticancer cell proliferation agent that exerts significant antiproliferative effects on HCT116, HepG2, H1299 and MCF-7.
  • HY-134230A
    L-2-Aminooxy-3-phenylpropanoic acid hydrobromide
    Inhibitor
    L-2-Aminooxy-3-phenylpropanoic acid hydrobromide is a potent inhibitor of L-phenylalanine ammonia-lyase.
  • HY-146466
    Anticancer agent 61
    Inhibitor
    Anticancer agent 61 (compound 3v) is an orally active and potent anticancer agent. Anticancer agent 61 shows antiproliferative activity in HepG2, Bel-7402 and MCF-7 cancer cells, with IC50 values of 1.12, 1.97 and 1.08 μM, respectively. Anticancer agent 61 shows effective tumor growth inhibition.
  • HY-139723
    Antidepressant agent 2
    Inhibitor
    Antidepressant agent 2 exerts pronounced antidepressant activity (MED 0.1 mg/kg).
  • HY-W550494
    1-(Pyridin-4-yl)heptan-1-one
    Inhibitor
    1-(Pyridin-4-yl)heptan-1-one (Compound R=n-C₆H₁₃) is an anticonvulsant agent. 1-(Pyridin-4-yl)heptan-1-one can protect mice from electroshock-induced convulsions. 1-(Pyridin-4-yl)heptan-1-one is promising for research of convulsion-related diseases such as epilepsy.
  • HY-132911
    Antiviral agent 6
    Inhibitor
    Antiviral agent 6 shows excellent anti-TSWV activity in vivo, and the EC50 value is 188 mg/L.
  • HY-118815
    Lodinixil
    Inhibitor
    Lodinixil is a cholesterol inhibitor. Lodinixil can be used in research on endocrine and metabolic diseases such as hyperlipidemia.
  • HY-139697
    HAV 3C proteinase-IN-1
    Inhibitor
    HAV 3C proteinase-IN-1 is a inhibitor of Hepatitis A virus 3C proteinase.
  • HY-131416
    DD-3305
    Inhibitor
    DD-3305 is an anti-inflammatory agent with comparable anti-inflammatory activity to the known anti-inflammatory agent indomethacin (HY-14397). In a carrageenin-induced rat inflammation model, DD-3305 was effective in inhibiting chronic and acute inflammation as well as induced allergies..
  • HY-139711
    Anticancer agent 13
    Inhibitor
    Anticancer agent 13 is an anticancer agent from dicarboxylic acids and amines.
  • HY-139733
    β-N-Acetyl-D-hexosaminidase-IN-1
    Inhibitor
    β-N-Acetyl-D-hexosaminidase-IN-1 is a novel β-N-acetyl-d-hexosaminidase inhibitor with a Ki value of 3.72 μM.
  • HY-177700
    Immunosuppressant-2
    Inhibitor
    Immunosuppressant-2 (Example 21) is an orally active immunosuppressant. Immunosuppressant-2 significantly reduces the number of circulating lymphocytes. Immunosuppressant-2 can be used for research on various autoimmune diseases and organ transplant rejection.
  • HY-153878
    BCAT-IN-4
    Inhibitor
    BCAT-IN-4 (Compound 1) is a BCAT inhibitor. BCAT-IN-4 exhibits a moderate ability to inhibit hBCATc with IC50 value of 2.35 μM. BCAT-IN-4 can be used for the research of neurodegenerative diseases.